Sepp Lorenzino Laura Insider Trades

Insider Trading History

Track insider trading activity for Sepp Lorenzino Laura. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexeo Therapeutics
Lexeo Therapeutics LXEO
Director
Holding Value $239k 50,000 shares
Last Trade
Apr 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 50,000 shares
$5.81
$4.78
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $667k 113,246 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 113,246 shares
$2.79
$5.89
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.14M 77,388 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 8,966 shares
$12.18
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.27M 86,354 shares
Last Trade
Jan 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.8k 3,500 shares
$11.66
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jan 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.8k 3,500 shares
$11.66
$14.75
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $580k 98,440 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 98,440 shares
$3.17
$5.89
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $1.21M 81,893 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 54,794 shares
$32.66
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $658k 44,594 shares
Last Trade
Jan 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$65.7k 2,275 shares
$28.87
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $681k 46,202 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$163k 5,532 shares
$29.46
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $763k 51,734 shares
Last Trade
Jan 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,500 shares
$30.49
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $51.6k 3,500 shares
Last Trade
Jan 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$107k 3,500 shares
$30.49
$14.75
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $213k 36,200 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.1k 36,200 shares
$0.72
$5.89
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $702k 47,567 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 42,302 shares
$40.75
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $270k 18,318 shares
Last Trade
Jan 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$89.7k 2,330 shares
$38.48
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $294k 19,959 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.3k 2,508 shares
$37.21
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $331k 22,467 shares
Last Trade
Jan 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 3,500 shares
$34.89
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $103k 7,000 shares
Last Trade
Jan 01, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 3,500 shares
$34.89
$14.75
Taysha Gene Therapies
Taysha Gene Therapies TSHA
Director
Holding Value $91.3k 15,500 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 15,500 shares
$2.81
$5.89
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $275k 18,631 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 13,816 shares
$79.85
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Scientific Officer
Holding Value $298k 20,203 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.61M 20,203 shares
$79.85
$14.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up